Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Neutralization of the SARS-CoV-2 Delta variant after heterologous and homologous BNT162b2 or ChAdOx1 nCoV-19 vaccination

23 Aug 2021

Abstract excerpt

Since the beginning of the COVID-19 pandemic, divergent variants of concern (VoCs) of SARS-CoV-2 have evolved and become the most prevalent SARS-CoV-2 variants in distinct locations at different times. Currently, the Delta variant (B.1.617.2) dominates infection events in large parts of the world. Immunization campaigns, however, still use SARS-CoV-2 vaccines based on the spike (S) protein of the original Wuhan...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to COVID-19 Clinical Research Studies
Share to Heparin-Induced Thrombocytopenia and Thrombosis
Share to SARS-CoV-2 and COVID-19 Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 34426672
DOI: 10.1038/s41423-021-00755-z

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Neutralization of the SARS-CoV-2 Delta variant after heterologous and homologous BNT162b2 or ChAdOx1 nCoV-19 vaccinationPMID 34426672Read ↗

SARS-CoV-2 delta variant neutralisation after heterologous ChAdOx1-S/BNT162b2 vaccinationSemantic proximity Read ↗

Antibody neutralization to SARS-CoV-2 and variants after one year in WuhanSemantic proximity Read ↗

COVID-19 mRNA vaccine induced antibody responses and neutralizing antibodies against three SARS-CoV-2 variantsSemantic proximity Read ↗

BNT162b2-Elicited Neutralization against New SARS-CoV-2 Spike VariantsSemantic proximity Read ↗

Variants of SARS-CoV-2, their effects on infection, transmission and neutralization by vaccine-induced antibodies.Semantic proximity Read ↗

The effect of SARS-CoV-2 D614G mutation on BNT162b2 vaccine-elicited neutralizationSemantic proximity Read ↗

Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity.Semantic proximity Read ↗

Ad26.COV2.S elicited neutralizing activity against Delta and other SARS-CoV-2 variants of concernSemantic proximity Read ↗

Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunitySemantic proximity Read ↗

Reduced neutralization of SARS-CoV-2 B.1.617 variant by inactivated and RBD-subunit vaccineSemantic proximity Read ↗

SARS-CoV-2 Delta derivatives impact on neutralization of Covishield recipient seraSemantic proximity Read ↗

Current Review of Delta Variant of SARS-CoV-2Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.